ZA200107502B - Lipoglycan compositions and methods of treating parasitic infections. - Google Patents

Lipoglycan compositions and methods of treating parasitic infections.

Info

Publication number
ZA200107502B
ZA200107502B ZA200107502A ZA200107502A ZA200107502B ZA 200107502 B ZA200107502 B ZA 200107502B ZA 200107502 A ZA200107502 A ZA 200107502A ZA 200107502 A ZA200107502 A ZA 200107502A ZA 200107502 B ZA200107502 B ZA 200107502B
Authority
ZA
South Africa
Prior art keywords
lipoglycan
compositions
methods
parasitic infections
composition
Prior art date
Application number
ZA200107502A
Other languages
English (en)
Inventor
Lloyd H Semprevivo
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of ZA200107502B publication Critical patent/ZA200107502B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
ZA200107502A 1999-03-12 2001-09-11 Lipoglycan compositions and methods of treating parasitic infections. ZA200107502B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12393199P 1999-03-12 1999-03-12

Publications (1)

Publication Number Publication Date
ZA200107502B true ZA200107502B (en) 2003-02-26

Family

ID=22411778

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200107502A ZA200107502B (en) 1999-03-12 2001-09-11 Lipoglycan compositions and methods of treating parasitic infections.

Country Status (17)

Country Link
US (3) US6428793B1 (de)
EP (1) EP1175226B1 (de)
JP (1) JP2002538220A (de)
AT (1) ATE439857T1 (de)
AU (1) AU771373B2 (de)
BR (1) BR0008949A (de)
CA (1) CA2364507A1 (de)
DE (1) DE60042776D1 (de)
HU (1) HUP0200466A3 (de)
MA (1) MA25347A1 (de)
MX (1) MXPA01009206A (de)
NO (1) NO20014411L (de)
NZ (1) NZ514112A (de)
PL (1) PL203789B1 (de)
TR (3) TR200202066T2 (de)
WO (1) WO2000053220A1 (de)
ZA (1) ZA200107502B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US7164520B2 (en) 2004-05-12 2007-01-16 Idc, Llc Packaging for an interferometric modulator
WO2006041613A2 (en) * 2004-10-05 2006-04-20 Nanomega Medical Corporation Nanoparticles for targeting hepatoma cells
EP2494980A3 (de) * 2009-10-21 2013-03-13 ETH Zurich Medizinische Nützlichkeit von Glycanen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2598147B1 (fr) * 1986-04-30 1988-08-26 Pasteur Institut Immunogene isole de mollusques, son procede de preparation, reactifs de diagnostic des bilharzioses humaines, vaccins contre les schistosomiases et compositions immunisantes comprenant ledit immunogene.
FR2601021B2 (fr) * 1986-07-07 1988-11-18 Pasteur Institut Fraction immunogene active a l'egard des bilharzioses, sa preparation, compositions immunisantes la contenant
US5280113A (en) * 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5212298A (en) 1989-08-16 1993-05-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
US5679347A (en) * 1992-12-10 1997-10-21 Brigham And Women's Hospital Methods of isolating CD1-presented antigens, vaccines comprising CD1-presented antigens, and cell lines for use in said methods
US5541075A (en) * 1993-02-05 1996-07-30 Heska Corporation Carbohydrate-based vaccine and diagnostic reagent for trichinosis
BR9305075A (pt) * 1993-12-16 1995-08-08 Fundacao Oswaldo Cruz Antígeno para conferir imunidade protetora contra infecções helmínticas em humanos e animais,e processo de vacinação para aplicação na imunoprofilaxia de doenças helmintológicas de interesse veterinário e médico
AU5928999A (en) * 1998-09-21 2000-04-10 Richard D. Cummings Assays for helminth infections

Also Published As

Publication number Publication date
BR0008949A (pt) 2002-09-24
TR200202066T2 (tr) 2004-12-21
PL203789B1 (pl) 2009-11-30
US20020160021A1 (en) 2002-10-31
NO20014411D0 (no) 2001-09-11
PL350989A1 (en) 2003-02-24
US7204983B2 (en) 2007-04-17
EP1175226A1 (de) 2002-01-30
TR200202078T2 (tr) 2002-11-21
US6428793B1 (en) 2002-08-06
CA2364507A1 (en) 2000-09-14
EP1175226A4 (de) 2005-01-05
HUP0200466A2 (en) 2002-06-29
WO2000053220A1 (en) 2000-09-14
EP1175226B1 (de) 2009-08-19
TR200103231T2 (tr) 2002-03-21
AU771373B2 (en) 2004-03-18
DE60042776D1 (de) 2009-10-01
HUP0200466A3 (en) 2006-11-28
NO20014411L (no) 2001-11-09
AU3625100A (en) 2000-09-28
US7063848B2 (en) 2006-06-20
JP2002538220A (ja) 2002-11-12
MXPA01009206A (es) 2003-07-14
NZ514112A (en) 2003-08-29
MA25347A1 (fr) 2001-12-31
ATE439857T1 (de) 2009-09-15
US20060228382A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
HU9601312D0 (en) Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
AU4806197A (en) Method and potentiated composition for treating migraine
ZA96101B (en) Imidazol[4,5-c]quinoline amines
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
GR3032037T3 (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
CA2366702A1 (en) Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
NO943920D0 (no) Vaksineadjuvans
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
AU7877900A (en) Method of obtaining cellular immune responses from proteins
GB9306731D0 (en) Vaccines
EP0979080A4 (de) Verfahren zur modulation der immunreaktion in einem infektierten säugetier mittels transmukosales eingeben eines modulationsmittel
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
AU2003212170A1 (en) Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
PL350989A1 (en) Lipoglycan compositions and methods of treating parasitic infections
BR9806971A (pt) Epìtopes de célula t universal para vacinas anti-malária.
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
WO2001039765A3 (en) Compositions and methods for the induction and treatment of retinal detachments
WO2000057908A3 (en) Attenuated dengue-1 virus vaccine
WO2001034184A3 (en) Methods and compositions for protection against bovine herpesvirus 1
CA2063721A1 (fr) Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae
EP1131338A4 (de) Methode für die herstellung von gereinigtem invasinprotein und seine anwendung
AU2471201A (en) Plant lectins as mucosal adjuvants
WO2001002005A3 (en) Treatment of dentritic cells for induction of immune tolerance
MY104932A (en) Immunomodulatory azaspiranes